Patterns of Spread in Ocular Melanoma
Study examines lymphatic and distant metastasis risk
-
By
-
Jess Allerton
-
February 18, 2026
-
Clinical Scorecard: Patterns of Spread in Ocular Melanoma
At a Glance
| Category | Detail |
|---|
| Condition | Conjunctival Malignant Melanoma |
| Key Mechanisms | Tumor location and stage influence metastatic risk; local recurrence correlates with distant metastasis. |
| Target Population | Patients diagnosed with conjunctival malignant melanoma, average age 63. |
| Care Setting | Retrospective study conducted at two German centers. |
Key Highlights
- 25% of patients developed metastatic disease during long-term follow-up.
- Local recurrence occurred in 47% of patients at a mean of 42 months.
- cT1 tumors linked to lower rates of metastasis compared to cT2 tumors.
- Adjuvant therapy associated with lower rates of systemic spread.
- Ruthenium-106 brachytherapy linked to reduced risk of hematogenous metastasis.
Guideline-Based Recommendations
Diagnosis
- Clinical staging of tumors (cT1, cT2) is essential for assessing metastatic risk.
Management
- Consider adjuvant therapy for pT1 tumors to reduce systemic spread.
Monitoring & Follow-up
- Regular surveillance strategies should be refined based on tumor location and recurrence patterns.
Risks
- Patients with local recurrence have increased risk of distant metastasis.
Patient & Prescribing Data
167 patients treated between 1985 and 2013.
Approximately 75% of patients received adjuvant therapy, with Ruthenium-106 brachytherapy showing benefits.
Clinical Best Practices
- Monitor for local recurrence as it is strongly associated with distant metastasis.
- Utilize clinical staging to guide treatment and surveillance strategies.
References
